Nutex Health chief operating officer Joshua DeTillio to resign in August
Investing.com
Published Jul 11, 2025 06:15PM ET
Nutex Health Inc. (NASDAQ:NUTX), a healthcare company currently rated with "GREAT" financial health according to InvestingPro analysis, announced that chief operating officer Joshua DeTillio has informed the company of his decision to resign from his position, effective August 8, 2025. According to a statement released in a SEC filing, DeTillio is leaving to assume a chief executive officer role at another company.
The company stated that DeTillio’s resignation is not the result of any dispute or disagreement with Nutex Health, its management, or its board of directors on any matter related to operations, policies, or practices.
Nutex Health’s board of directors has begun a comprehensive search for candidates to replace DeTillio as chief operating officer.
This information is based on a press release statement included in a recent SEC filing.
In other recent news, Nutex Health reported a remarkable 214% increase in first-quarter revenue year-over-year, reaching $211.8 million, surpassing Benchmark's estimate of $121 million. The revenue boost was largely due to successful arbitration outcomes under the No Surprise Act, contributing approximately $105 million. Nutex Health's operational strategy included submitting 60-70% of patient visits to arbitration, achieving an over 80% success rate. Benchmark analysts responded to these strong results by raising the company's stock target to $300, maintaining a Buy rating. Nutex Health also announced plans to open three new hospitals in Texas later in 2025. Additionally, the company has appointed Grant Thornton LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. The change in auditors follows the dismissal of CBIZ (NYSE:CBZ) CPAs P.C., with Nutex Health citing no "reportable events" except for identified material weaknesses in internal controls. These developments highlight Nutex Health's ongoing efforts to enhance financial performance and expand its healthcare services.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.